<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02678650</url>
  </required_header>
  <id_info>
    <org_study_id>2015017X</org_study_id>
    <nct_id>NCT02678650</nct_id>
  </id_info>
  <brief_title>MicroRNA Mediates Volatile Anesthetics Preconditioning Induced Artery Protection</brief_title>
  <official_title>Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Liang Zhang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Anzhen Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has been reported that volatile anesthetics preconditioning mediates protection of organ&#xD;
      via microRNA. We want to study on the effects of isoflurane preconditioning on expression of&#xD;
      microRNA and mRNA in the specimens of internal mammary artery and ascending aorta.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Sixty patients scheduled for off-pump coronary artery bypass surgery were randomly&#xD;
           assigned to isoflurane wash-in/wash-out group(S-I group, n=30)or propofol intravenous&#xD;
           anesthesia group(P group, n=30).&#xD;
&#xD;
        2. Anesthesia and monitoring method All patients were monitored according to the American&#xD;
           Society of Anesthesia guidelines and received standard general induction of anesthesia.&#xD;
&#xD;
        3. SI group:10min after intubation,begin to isoflurane wash-in/wash-out&#xD;
           operation:isoflurane administration was interrupted for at least 10 min,by washout with&#xD;
           a high fresh gas flow(10 l/min)to achieve a MAC value below 0.2. Following the&#xD;
           interruption,sevoflurane was again washed in with a high fresh gas flow(6 l/min)to&#xD;
           achieve 1 MAC end-tidal concentration as soon as possible,and repeated twice periods of&#xD;
           10 minutes.Discontinuation of the halogenated agent for at least 15 minutes during the&#xD;
           last wash out time.&#xD;
&#xD;
        4. P Group:propofol infusion 3-5μg/kg/h.&#xD;
&#xD;
        5. When isoflurane inhaled anesthetic,propofol are stopped infusion.If during this&#xD;
           interruption the BIS value increased to&gt;50,0.5 mg/kg propofol was administered&#xD;
           repeatedly in boluses until the BIS value have returned to&lt;50.&#xD;
&#xD;
      6.1h after isoflurane preconditioning,specimens of internal mammary artery(surplus arterial&#xD;
      tissue is obtained from the repair internal mammary artery)and ascending aorta(the stump&#xD;
      after ascending aortic punch)will be saved, and before isoflurane preconditioning,1h,3h,5h&#xD;
      after isoflurane preconditioning, central venous blood samples will also be drawn.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2016</start_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>microRNA</measure>
    <time_frame>1h after isoflurane treatment(specimens of internal mammary artery and ascending aorta stump are saved)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>NOS3 mRNA,mRNA levels of adhesion molecule selectin -E,vascular cell adhesion molecule -1,vascular endothelial growth factor -1,intercellular adhesion molecule,RhoA and ROK</measure>
    <time_frame>1h after isoflurane treatment(specimens of internal mammary artery and ascending aorta stump are saved)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>phosphatidylinositol-3-kinase,alanine aminotransferase,endothelial nitric oxide synthase</measure>
    <time_frame>1h after isoflurane treatment(specimens of internal mammary artery and ascending aorta stump are saved)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from microRNA</measure>
    <time_frame>befor isoflurane treatment,1h,3h,5h after isoflurane treatment(central venous blood samples are drawn)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from ON content in serum,vascular cell adhesion molecule-1,intercellular adhesion molecules-1,adhesion molecule selectin-E,monocyte chemoattractant protein-1 and vascular endothelial growth factor-1</measure>
    <time_frame>befor isoflurane treatment,1h,3h,5h after isoflurane treatment(central venous blood samples are drawn)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from tumor necrosis factor-a,interleukin 1β,IL-6,IL-8 and IL-10</measure>
    <time_frame>befor isoflurane treatment,1h,3h,5h after isoflurane treatment(central venous blood samples are drawn)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Coronary Artery Bypass Graft Triple Vessel</condition>
  <arm_group>
    <arm_group_label>volatile anesthetics group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10min after intubation, begin to sevoflurane wash-in / wash-out operation: sevoflurane administration was interrupted for at least 10 min, by washout with a high fresh gas flow (10 l/min) to achieve a MAC value below 0.2. Following the interruption, sevoflurane was again washed in with a high fresh gas flow (6 l/min) to achieve 1 MAC end-tidal concentration as soon as possible, and repeated twice periods of 10 minutes. Discontinuation of the halogenated agent for at 15 minutes during the last wash out time.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>propofol intravenous anesthesia group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>propofol infusion 3-5μg / kg / h</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>volatile anesthetics(isoflurane)</intervention_name>
    <description>volatile anesthetics wash-in / wash-out operation</description>
    <arm_group_label>volatile anesthetics group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol intravenous anesthesia</intervention_name>
    <description>propofol infusion 3-5μg / kg / h</description>
    <arm_group_label>propofol intravenous anesthesia group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age &gt;18 years&#xD;
&#xD;
          -  written informed consent;&#xD;
&#xD;
          -  scheduled procedures;&#xD;
&#xD;
          -  planned isolated OPCABG(multiple bypass are allowed; planned combined intervention&#xD;
             such as CABG plus valve surgery are not allowed);&#xD;
&#xD;
          -  ejection fraction&gt; 50%;&#xD;
&#xD;
          -  NYHA class Ⅱ~Ⅲ;&#xD;
&#xD;
          -  serum creatinine &lt;150μmol / l;&#xD;
&#xD;
          -  preoperative platelet content &gt; 100 × 109 / l;&#xD;
&#xD;
          -  preoperative hemoglobin&gt; 120 g / l&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy;&#xD;
&#xD;
          -  planned valve surgery or surgery on the aorta;&#xD;
&#xD;
          -  left main coronary artery stenosis&gt; 75%;&#xD;
&#xD;
          -  echocardiographic examination revealed moderate to severe mitral, tricuspid, or aortic&#xD;
             regurgitation or stenosis;&#xD;
&#xD;
          -  unstable or ongoing angina;&#xD;
&#xD;
          -  recent (&lt; 1 month) or ongoing acute myocardial infarction;&#xD;
&#xD;
          -  use of sulfonylurea, theophylline or allopurinol;&#xD;
&#xD;
          -  previous unusual response to an anesthetic agent;&#xD;
&#xD;
          -  inclusion in other randomised controlled studies in the previous 30 days; (10)any&#xD;
             general anesthesia performed in the previous 30 days;&#xD;
&#xD;
          -  emergency operation (not scheduled);&#xD;
&#xD;
          -  kidney or liver transplant in medical history, liver cirrhosis (Child B or C);&#xD;
&#xD;
          -  chronic respiratory disease (such as chronic obstructive pulmonary emphysema)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jun Ma, MD</last_name>
    <phone>010-64456329</phone>
    <email>majun7689@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Anzhen Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100038</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jun Ma, MD</last_name>
      <phone>010-64456329</phone>
      <email>majun7689@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <study_first_submitted>January 23, 2016</study_first_submitted>
  <study_first_submitted_qc>February 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2016</study_first_posted>
  <last_update_submitted>February 5, 2016</last_update_submitted>
  <last_update_submitted_qc>February 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Anzhen Hospital</investigator_affiliation>
    <investigator_full_name>Liang Zhang</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Volatile Anesthetics</keyword>
  <keyword>MicroRNA</keyword>
  <keyword>Off-pump Coronary Artery Bypass Surgery</keyword>
  <keyword>Internal Mammary Artery</keyword>
  <keyword>Ascending Aorta</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

